6533b860fe1ef96bd12c3a84

RESEARCH PRODUCT

The posterior chamber phakic refractive lens (PRL): a review

Teresa Ferrer-blascoAlejandro CerviñoRafael J. Pérez-cambrodíRune BrautasetDavid P. Piñero

subject

Phakic Intraocular Lensesmedicine.medical_specialtygenetic structuresmedicine.medical_treatmentVisual performanceOptical qualityReviewAstigmatismRefraction OcularPhakic intraocular lensPhakic refractive lens (PRL)CataractPupilEndophthalmitisLens Implantation IntraocularCataractsOphthalmologyRefractive surgeryMyopiamedicineHumansRefractive surgeryÓpticaPosterior chamber phakic intraocular lensbusiness.industryPatient SelectionEquipment Designmedicine.diseaseeye diseasesOphthalmologyAberrations of the eyemedicine.anatomical_structureLens (anatomy)Posterior Capsule of the LensOptometrysense organsbusiness

description

Implantation of phakic intraocular lenses (pIOLs) is a reversible refractive procedure, preserving the patient’s accommodative function with minimal induction of higher order aberrations compared with corneal photoablative procedures. Despite this, as an intraocular procedure, it has potential risks such as cataracts, chronic uveitis, pupil ovalization, corneal endothelial cell loss, pigmentary dispersion syndrome, pupillary block glaucoma, astigmatism, or endophthalmitis. Currently, only two models of posterior chamber pIOLs are commercially available, the implantable collammer lens (STAAR Surgical Co.) and the phakic refractive lens (PRL; Zeiss Meditec). The number of published reports on the latter is very low, and some concerns still remain about its long-term safety. The present article reviews the published literature on the outcomes after PRL implantation in order to provide a general overview and evaluate its real potential as a surgical refractive option.

yearjournalcountryeditionlanguage
2012-12-07Eye
https://doi.org/10.1038/eye.2012.235